Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

EQUITY ALERT: Rosen Law Firm Reminds Impax Laboratories' Investors of Important Class Action Deadline -- IPXL

IPXL

NEW YORK, Aug. 29, 2014 (GLOBE NEWSWIRE) -- The Rosen Law Firm reminds all purchasers of Impax Laboratories Inc. (Nasdaq:IPXL) securities between May 20, 2013 and July 28, 2014, of the important October 13, 2014 lead plaintiff deadline in the class action.

To join the Impax class action, go to the website at http://rosenlegal.com/cases-333.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or kchan@rosenlegal.com for information on the class action.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.

According to the lawsuit, Impax misrepresented and failed to disclose quality control issues at the Company's Taiwan production facility. Specifically, the Company made material misrepresentations concerning: (i) its failure to adhere to proper quality control and manufacturing practices at its Taiwan production facility; (ii) the potential material adverse effect of its quality control and manufacturing issues on its ability to launch its new drug, RYTARY; (iii) the quality control and manufacturing issues imperiling its ability to produce, sell, and distribute generic drugs; and (iv) the absence of a reasonable basis for the Defendants' positive statements concerning the Impax and its prospects. The lawsuit claims that when this adverse information entered the market, the price of Impax's securities dropped, damaging investors.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 13, 2014. If you wish to join the litigation go to http://rosenlegal.com/cases-333.html. To discuss your rights or interests regarding this class action, please contact, Phillip Kim, Esq. or Kevin Chan, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com or kchan@rosenlegal.com.

The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

CONTACT: Laurence Rosen, Esq.
         Phillip Kim, Esq.
         Kevin Chan, Esq.
         The Rosen Law Firm P.A.
         275 Madison Avenue 34th Floor
         New York, New York 10016
         Tel: (212) 686-1060
         Toll Free: 1-866-767-3653
         Fax: (212) 202-3827
         lrosen@rosenlegal.com
         pkim@rosenlegal.com
         kchan@rosenlegal.com
         www.rosenlegal.com

Rate this press release
3 stars
v
Usefulness

Clarity

Credibility
Add to favourites icon Add to favourites